This study is in progress, not accepting new patients
Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC
Summary
- Eligibility
- for people ages 5-30 (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Rajsekar Rajaraman
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Rajsekar Rajaraman
Hs Associate Clinical Professor, Pediatrics, Medicine. Authored (or co-authored) 26 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Noema Pharma AG
- ID
- NCT05059327
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- About 61 people participating
- Last Updated